These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36083484)

  • 21. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
    Kolijn D; Kovács Á; Herwig M; Lódi M; Sieme M; Alhaj A; Sandner P; Papp Z; Reusch PH; Haldenwang P; Falcão-Pires I; Linke WA; Jaquet K; Van Linthout S; Mügge A; Tschöpe C; Hamdani N
    Front Physiol; 2020; 11():345. PubMed ID: 32523538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
    Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
    Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tongmai Yangxin pill reduces myocardial No-reflow via endothelium-dependent NO-cGMP signaling by activation of the cAMP/PKA pathway.
    Chen R; Chen T; Wang T; Dai X; Zhang S; Jiang D; Meng K; Wang Y; Geng T; Xu J; Zhou K; Wang Y
    J Ethnopharmacol; 2021 Mar; 267():113462. PubMed ID: 33058924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SLC8A1-AS1 protects against myocardial damage through activation of cGMP-PKG signaling pathway by inhibiting SLC8A1 in mice models of myocardial infarction.
    Guo GL; Sun LQ; Sun MH; Xu HM
    J Cell Physiol; 2019 Jun; 234(6):9019-9032. PubMed ID: 30378115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current trends and future perspectives for heart failure treatment leveraging cGMP modifiers and the practical effector PKG.
    Nakamura T; Tsujita K
    J Cardiol; 2021 Oct; 78(4):261-268. PubMed ID: 33814252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of Connexin 40 Mediated by Nitric Oxide Attenuates Cerebral Vasospasm After Subarachnoid Hemorrhage via the Nitric Oxide-Cyclic Guanosine Monophosphate-Protein Kinase G Pathway.
    Lan SH; Lai WT; Zheng SY; Yang L; Fang LC; Zhou L; Tang B; Duan J; Hong T
    World Neurosurg; 2020 Apr; 136():e476-e486. PubMed ID: 31953101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YQWY decoction reverses cardiac hypertrophy induced by TAC through inhibiting GATA4 phosphorylation and MAPKs.
    Huang JJ; Xie Y; Li H; Zhang XX; Huang Q; Zhu Y; Gu P; Jiang WM
    Chin J Nat Med; 2019 Oct; 17(10):746-755. PubMed ID: 31703755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction.
    Monma Y; Shindo T; Eguchi K; Kurosawa R; Kagaya Y; Ikumi Y; Ichijo S; Nakata T; Miyata S; Matsumoto A; Sato H; Miura M; Kanai H; Shimokawa H
    Cardiovasc Res; 2021 Apr; 117(5):1325-1338. PubMed ID: 32683442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRD-733, a Novel PDE9 (Phosphodiesterase 9) Inhibitor, Reverses Pressure Overload-Induced Heart Failure.
    Richards DA; Aronovitz MJ; Liu P; Martin GL; Tam K; Pande S; Karas RH; Bloomfield DM; Mendelsohn ME; Blanton RM
    Circ Heart Fail; 2021 Jan; 14(1):e007300. PubMed ID: 33464954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway.
    Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G
    J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NO-cGMP-PKG pathway in skeletal remodeling.
    Kim SM; Yuen T; Iqbal J; Rubin MR; Zaidi M
    Ann N Y Acad Sci; 2021 Mar; 1487(1):21-30. PubMed ID: 32860248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vasodilatory effect of sulfur dioxide via SGC/cGMP/PKG pathway in association with sulfhydryl-dependent dimerization.
    Yao Q; Huang Y; Liu AD; Zhu M; Liu J; Yan H; Zhang Q; Geng B; Gao Y; Du S; Huang P; Tang C; Du J; Jin H
    Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1073-80. PubMed ID: 27009048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
    Zhang Y; Li SY; Xie JJ; Wu Y
    Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation.
    Kolijn D; Pabel S; Tian Y; Lódi M; Herwig M; Carrizzo A; Zhazykbayeva S; Kovács Á; Fülöp GÁ; Falcão-Pires I; Reusch PH; Linthout SV; Papp Z; van Heerebeek L; Vecchione C; Maier LS; Ciccarelli M; Tschöpe C; Mügge A; Bagi Z; Sossalla S; Hamdani N
    Cardiovasc Res; 2021 Jan; 117(2):495-507. PubMed ID: 32396609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
    Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta.
    Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM
    Life Sci; 2021 May; 272():119223. PubMed ID: 33610574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
    Wong JC; Fiscus RR
    J Cell Biochem; 2011 Mar; 112(3):829-39. PubMed ID: 21328456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
    Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.